0
selected
-
1.
Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial.
Dai, Q, Zhu, X, Manson, JE, Song, Y, Li, X, Franke, AA, Costello, RB, Rosanoff, A, Nian, H, Fan, L, et al
The American journal of clinical nutrition. 2018;(6):1249-1258
-
-
Free full text
-
Abstract
BACKGROUND Previous in vitro and in vivo studies indicate that enzymes that synthesize and metabolize vitamin D are magnesium dependent. Recent observational studies found that magnesium intake significantly interacted with vitamin D in relation to vitamin D status and risk of mortality. According to NHANES, 79% of US adults do not meet their Recommended Dietary Allowance of magnesium. OBJECTIVES The aim of this study was to test the hypothesis that magnesium supplementation differentially affects vitamin D metabolism dependent on baseline 25-hydroxyvitamin D [25(OH)D] concentration. METHODS The study included 180 participants aged 40-85 y and is a National Cancer Institute independently funded ancillary study, nested within the Personalized Prevention of Colorectal Cancer Trial (PPCCT), which enrolled 250 participants. The PPCCT is a double-blind 2 × 2 factorial randomized controlled trial conducted in the Vanderbilt University Medical Center. Doses for both magnesium and placebo were customized based on baseline dietary intakes. Subjects were randomly assigned to treatments using a permuted-block randomization algorithm. Changes in plasma 25-hydroxyvitamin D3 [25(OH)D3], 25-hydroxyvitamin D2 [25(OH)D2], 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and 24,25-dihydroxyvitamin D3 [24,25(OH)2D3] were measured by liquid chromatography-mass spectrometry. RESULTS The relations between magnesium treatment and plasma concentrations of 25(OH)D3, 25(OH)D2, and 24,25(OH)2D3 were significantly different dependent on the baseline concentrations of 25(OH)D, and significant interactions persisted after Bonferroni corrections. Magnesium supplementation increased the 25(OH)D3 concentration when baseline 25(OH)D concentrations were close to 30 ng/mL, but decreased it when baseline 25(OH)D was higher (from ∼30 to 50 ng/mL). Magnesium treatment significantly affected 24,25(OH)2D3 concentration when baseline 25(OH)D concentration was 50 ng/mL but not 30 ng/mL. On the other hand, magnesium treatment increased 25(OH)D2 as baseline 25(OH)D increased. CONCLUSION Our findings suggest that optimal magnesium status may be important for optimizing 25(OH)D status. This trial was registered at clinicaltrials.gov as NCT03265483.
-
2.
In vitro degradation kinetics of pure PLA and Mg/PLA composite: Effects of immersion temperature and compression stress.
Li, X, Chu, C, Wei, Y, Qi, C, Bai, J, Guo, C, Xue, F, Lin, P, Chu, PK
Acta biomaterialia. 2017;:468-478
Abstract
UNLABELLED The effects of the immersion temperature and compression stress on the in vitro degradation behavior of pure poly-lactic acid (pure-PLA) and PLA-based composite unidirectionally reinforced with micro-arc oxidized magnesium alloy wires (Mg/PLA or MAO-MAWs/PLA) are investigated. The degradation kinetics of pure-PLA and the PLA matrix in MAO-MAWs/PLA exhibit an Arrhenius-type behavior. For the composite, the synergic degradation of MAO-MAWs maintains a steady pH and mitigates the degradation of PLA matrix during immersion. However, the external compression stress decreases the activation energy (Ea) and pre-exponential factor (k0) consequently increasing the degradation rate of PLA. Under a compression stress of 1MPa, Ea and k0 of pure PLA are 57.54kJ/mol and 9.74×107day-1, respectively, but 65.5kJ/mol and 9.81×108day-1 for the PLA matrix in the composite. Accelerated tests are conducted in rising immersion temperature in order to shorten the experimental time. Our analysis indicates there are well-defined relationships between the bending strength of the specimens and the PLA molecular weight during immersion, which are independent of the degradation temperature and external compression stress. Finally, a numerical model is established to elucidate the relationship of bending strength, the PLA molecular weight, activation energy, immersion time and temperature. STATEMENT OF SIGNIFICANCE We systematically evaluate the effects of compression stress and temperature on the degradation properties of two materials: (pure-PLA) and MAO-MAWs/PLA (or Mg/PLA). The initial in vitro degradation kinetics of the unstressed or stressed pure-PLA and MAO-MAWs/PLA composite is confirmed to be Arrhenius-like. MAO-MAWs and external compression stress would influence the degradation activation energy (Ea) and pre-exponential factor (k0) of PLA, and we noticed there is a linear relationship between Ea and ln k0. Thereafter, we noticed that Mg2+, not H+, plays a significant role on the mitigation of the PLA degradation and external compression stress brings the molecular structure change of PLA. Finally, we proposed a model to predict the bending strength of the specimens versus immersion time at different immersion temperatures. This fundamental study could provide some scientific basis in our understanding for the evaluations and biomedical applications of these biodegradable materials.
-
3.
Synthesis, characterization and biological evaluation of strontium/magnesium-co-substituted hydroxyapatite.
Geng, Z, Wang, R, Li, Z, Cui, Z, Zhu, S, Liang, Y, Liu, Y, Huijing, B, Li, X, Huo, Q, et al
Journal of biomaterials applications. 2016;(1):140-51
Abstract
The present study aims to investigate the contribution of two biologically important cations, Mg(2+) and Sr(2+), when co-substituted into the structure of hydroxyapatite (Ca10(PO4)6(OH)2, HA). The substituted samples were synthesized by a hydrothermal method that involved the addition of Mg(2+) and Sr(2+) containing precursors to partially replace Ca(2+) in the apatite structure. Four co-substituted HA samples with different concentrations of Mg(2+) and Sr(2+) ((Mg + Sr)/(Mg + Sr + Ca) = 30%) were investigated, and they were compared with pure HA. Experimental results showed that only a limited amount of Mg (Mg/(Mg + Ca + Sr) < 14%) could successfully substitute for Ca in HA. In addition, Mg substitution resulted in reduced crystallinity, thermal stability and lattice parameters of HA. In contrast, Sr could fully substitute for Ca. Furthermore, the addition of Sr increased the lattice parameters of HA. Here, we obtained the cation leach liquor by immersing the prepared samples in a culture medium for cell experiments. The in vitro study showed that 10Mg20Sr promoted better MG63 cell attachment, proliferation and differentiation than HA. Thus, the presence of an appropriate proportion of Mg and Sr could play a significant role in the increased biocompatibility of HA.
-
4.
Biodegradable poly-lactic acid based-composite reinforced unidirectionally with high-strength magnesium alloy wires.
Li, X, Chu, CL, Liu, L, Liu, XK, Bai, J, Guo, C, Xue, F, Lin, PH, Chu, PK
Biomaterials. 2015;:135-44
Abstract
Biodegradable poly-lactic acid (PLA)--based composites reinforced unidirectionally with high-strength magnesium alloy wires (MAWs) are fabricated by a heat-compressing process and the mechanical properties and degradation behavior are studied experimentally and theoretically. The composites possess improved strengthening and toughening properties. The bending strength and impact strength of the composites with 40 vol% MAWs are 190 MPa and 150 kJ/m(2), respectively, although PLA has a low viscosity and an average molecular weight of 60,000 g/mol. The mechanical properties of the composites can be further improved by internal structure modification and interface strengthening and a numerical model incorporating the equivalent section method (ESM) is proposed for the bending strength. Micro arc oxidization (MAO) of the MAWs is an effective interfacial strengthening method. The composites exhibit high strength retention during degradation and the PLA in the composite shows a smaller degradation rate than pure PLA. The novel biodegradable composites have large potential in bone fracture fixation under load-bearing conditions.
-
5.
Clinical severity of Gitelman syndrome determined by serum magnesium.
Jiang, L, Chen, C, Yuan, T, Qin, Y, Hu, M, Li, X, Xing, X, Lee, X, Nie, M, Chen, L
American journal of nephrology. 2014;(4):357-66
Abstract
BACKGROUND/AIMS: Normomagnesemia is considered atypical in Gitelman syndrome (GS). Here, we describe clinical, pathological and genetic characteristics in Chinese GS patients with or without hypomagnesemia in order to determine whether serum magnesium concentration indicates the severity of the disease. METHODS 7 normomagnesemic and 25 hypomagnesemic GS patients who were confirmed by direct sequencing of SLC12A3 gene were included. Clinical manifestation and laboratory tests were documented. Supine and upright plasma renin activity, angiotensin II and aldosterone were determined by radioimmunoassay. Transient receptor potential channel melastatin subtype 6 (TRPM6) was detected by immunohistochemistry in paraffin-embedded renal biopsy sections of 12 GS patients. 14 patients with glomerular minor lesion served as controls. The distribution of the mutations on the predicted NCC protein was analyzed and compared between two subgroups. RESULTS Clinical manifestations, electrolyte abnormalities, metabolic alkalosis and renin-angiotensin-aldosterone system activation were found to be milder in normomagnesemic compared with the hypomagnesemic group. Compared with glomerular minor lesion controls, the TRPM6-positive area was significantly decreased in hypomagnesemic patients (4.96 ± 1.88 vs. 8.63 ± 2.67%) while it was near normal (7.82 ± 5.23%) in 2 normomagnesemic GS patients. A higher percentage of intracellular mutations was observed in normomagnesemic patients than hypomagnesemic patients (92.31 vs. 56.52%, p = 0.02). CONCLUSIONS Normomagnesemia is not rare in GS. Serum magnesium may indicate the severity of GS.
-
6.
[Effect of magnesium ion content on the biological phosphorus removal system in SBR].
Li, X, Gao, DW, Liu, L
Huan jing ke xue= Huanjing kexue. 2011;(7):2036-40
Abstract
This study investigated the effect of magnesium iron content on the enhanced biological phosphorus removal system, which performed differently at magnesium content of 0 mg/L, 8 mg/L and 24 mg/L (R1-R3). The results indicated appropriate Mg addition could enrich phosphorus accumulating organisms and keep stable running. During the steady state period, phosphorus removal rate declined to below 50% gradually, moreover, the system tended to deteriorate with the shortage of magnesium in R1. However, the system with appropriate magnesium kept the higher phosphorus removal rate (more than 90%). The statistical analysis of the experimental data also showed a strong correlation between Mg and phosphorus concentrations in R2 and R3, the ratios of Mg and P were 0.29-0.59 and 0.25-0.54 in two reactors respectively. In the anaerobic phase of EBPR, the magnesium content, the absolute value of ORP and the phosphates release had a correlation. Meanwhile, magnesium was released together with phosphates in the anaerobic phase, and that would uptake under aerobic conditions. Thus it was obvious that magnesium played a key role on the biological phosphorus removal system.